Neurológia pre prax 6/2022
Application of antiCGRP prophylaxis episodic and chronic migraines in praxis
Migraine is the third most common neurological disease. It i also one of the most disabling disease in the world. They are around one million patients with migraine in the Czech Republic. At least 50 000 women and men suffer from chronic migraine. Since 1993, we have a specific acute antimigraine drug, triptans. Since 2020, targeted biological treatment has been available, which significantly reduces the number of migraine attacks and improves the patient’s quality of life.
Keywords: episodic and chronic migraine, prophylactic treatment, anti CGRP treatment
